Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. Immunicom's cancer therapy can allow the body’s natural immune system to directly attack cancer while enhancing the effects of other cancer treatments that may be used concurrently.

Biotechnology

Immunicom

Amir Jafri

Lawrence Florin

Adam Ostrowski

Kamel Djazouli

Dave L. Lopez

Marilyn Panahi

Raju Chauhan

Julie Tubbs

Johan Louw

Steven Josephs

Steve Prince

The current leadership team at Immunicom has a history of experience in the medical and scientific industries, with a focus on development and process management. They hold certificates and degrees from various institutions, such as UCSD Extension and GenStar Therapeutics, and have been involved with companies such as Bio-Matrix Scientific Group and THERINJECT LLC. Together, they bring a wealth of knowledge and experience to Immunicom.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Immunicom

Board of Directors

CEO and Executive Team